Compare SUVEN LIFE with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES SUN PHARMA SUVEN LIFESCIENCES/
SUN PHARMA
 
P/E (TTM) x 19.9 27.3 72.9% View Chart
P/BV x 4.0 2.4 171.1% View Chart
Dividend Yield % 0.5 0.7 77.1%  

Financials

 SUVEN LIFESCIENCES   SUN PHARMA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
SUN PHARMA
Mar-19
SUVEN LIFESCIENCES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs338679 49.7%   
Low Rs169375 45.1%   
Sales per share (Unadj.) Rs52.1121.1 43.0%  
Earnings per share (Unadj.) Rs6.813.4 51.1%  
Cash flow per share (Unadj.) Rs8.620.7 41.4%  
Dividends per share (Unadj.) Rs1.502.75 54.5%  
Dividend yield (eoy) %0.60.5 113.4%  
Book value per share (Unadj.) Rs65.3172.6 37.8%  
Shares outstanding (eoy) m127.282,399.26 5.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.94.4 111.8%   
Avg P/E ratio x37.139.4 94.2%  
P/CF ratio (eoy) x29.625.5 116.1%  
Price / Book Value ratio x3.93.1 127.2%  
Dividend payout %22.020.6 106.8%   
Avg Mkt Cap Rs m32,2721,264,650 2.6%   
No. of employees `0001.117.5 6.2%   
Total wages/salary Rs m66159,671 1.1%   
Avg. sales/employee Rs Th6,132.216,608.1 36.9%   
Avg. wages/employee Rs Th611.13,409.6 17.9%   
Avg. net profit/employee Rs Th803.51,833.8 43.8%   
INCOME DATA
Net Sales Rs m6,635290,659 2.3%  
Other income Rs m24210,255 2.4%   
Total revenues Rs m6,877300,914 2.3%   
Gross profit Rs m1,60463,076 2.5%  
Depreciation Rs m22117,533 1.3%   
Interest Rs m385,553 0.7%   
Profit before tax Rs m1,58750,246 3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m7186,009 11.9%   
Profit after tax Rs m86932,093 2.7%  
Gross profit margin %24.221.7 111.4%  
Effective tax rate %45.212.0 378.2%   
Net profit margin %13.111.0 118.7%  
BALANCE SHEET DATA
Current assets Rs m6,232310,692 2.0%   
Current liabilities Rs m1,490173,396 0.9%   
Net working cap to sales %71.547.2 151.3%  
Current ratio x4.21.8 233.4%  
Inventory Days Days8699 87.3%  
Debtors Days Days83112 74.0%  
Net fixed assets Rs m4,043232,477 1.7%   
Share capital Rs m1272,399 5.3%   
"Free" reserves Rs m8,183411,691 2.0%   
Net worth Rs m8,310414,091 2.0%   
Long term debt Rs m1815,226 0.1%   
Total assets Rs m10,389646,938 1.6%  
Interest coverage x43.110.0 428.9%   
Debt to equity ratio x00 5.8%  
Sales to assets ratio x0.60.4 142.2%   
Return on assets %8.75.8 150.1%  
Return on equity %10.57.8 135.0%  
Return on capital %19.510.2 191.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62266,025 8.5%   
Fx outflow Rs m1,79938,610 4.7%   
Net fx Rs m3,82227,415 13.9%   
CASH FLOW
From Operations Rs m35621,965 1.6%  
From Investments Rs m-279-6,813 4.1%  
From Financial Activity Rs m-225-27,305 0.8%  
Net Cashflow Rs m-148-8,442 1.8%  

Share Holding

Indian Promoters % 63.4 63.7 99.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.1 -  
FIIs % 0.0 23.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 8.3 439.8%  
Shareholders   37,287 133,026 28.0%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   UNICHEM LAB  SHASUN PHARMA  PFIZER  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 95 Points Higher; Automobile and IT Stocks Witness Buying(Closing)

Indian share markets traded rangebound throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the automobile sector.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Oct 23, 2019 03:37 PM

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - STERLING BIOTECH COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS